期刊文献+

老年2型糖尿病患者三餐加睡前胰岛素强化治疗使用地特胰岛素优于中性鱼精蛋白锌胰岛素

Meal-time insulin aspart plus bedtime determir was superior to plus bedtime NPH in the elderly T2DM patients
原文传递
导出
摘要 目的观察预混胰岛素血糖控制不佳的老年T2DM患者使用地特胰岛素联合门冬胰岛素的疗效。方法选取预混胰岛素血糖控制不佳的老年T2DM患者60例,分为地特胰岛素治疗(A)组及中性鱼精蛋白锌胰岛素(NPH)治疗(B)组各30例,观察两组治疗前后血糖变化、每日胰岛素用量、血糖达标时间和低血糖发生率。结果两组治疗后血糖均下降。与B组相比,A组血糖变化更平稳,血糖达标时间更短,每日胰岛素用量更少,低血糖发生率更低,差异有统计学意义。结论老年T2DM患者需(?)餐加睡前胰岛素强化治疗时,三餐前门冬胰岛素联合睡前地特胰岛素优于睡前NPH。 Objective To observe the clinical effect of insulin detemir in combination with insulin aspart on the elderly T2DM patients with poorly controlled blood glucose. Methods Totally 60 elderly T2DM patients with a poor response to premixed insulin were randomized into insulin detemir group (group A) and insulin neutral protamine hagedorn (NPH) group (group B) with 30 in each. Group A was treated with insulin detemir + insulin aspart, and group B with insulin NPH + insulin aspart. The changes in the level of blood glucose, insulin dosage, the time to target blood glucose, and the incidence of hypoglycemia of the two groups were observed and compared. Results The level of blood glucose of both groups after treatment was significantly lowered. As comparing with Group B, the decrease of blood glucose was faster, the daily insulin dosage was lower, the time to the target blood glucose was shorter, and the incidence of hypoglycemia was lower in group A, and the difference is statistically significant. Conclusion The effect of insulin detemir in combination with insulin aspart is superior to insulin NPH plus insulin aspart on elderly T2DM patients.
出处 《中国糖尿病杂志》 CAS CSCD 北大核心 2013年第9期811-813,共3页 Chinese Journal of Diabetes
关键词 地特胰岛素 门冬胰岛素 中性鱼精蛋白锌胰岛素 糖尿病 2型 Insulin detemir Insulin aspart Insulin neutral protamine hagedorn (NPH) Diabetesmellitus, type 2
  • 相关文献

参考文献5

  • 1Heise T,Eckers U,Kanc K. The pharmacokinetic and pharmacodynamic properties of different formulations of biphasic insulin aspart:a randomized,glucose clamp,crossover study[J].{H}Diabetes Technology & Therapeutics,2008.479-485.
  • 2Klein O,Lynge J,Endahl L. Albumin-bound basal insulin analogues (insulin detemir and NN344):comparable time-actionprofiles but less variability than insulin glargine in type 2 diabetes[J].{H}Diabetes Obesity & Metabolism,2007.290-299.
  • 3杨文英.地特胰岛素治疗2型糖尿病的耐受性、安全性和依从性[J].中华糖尿病杂志,2009,1(1). 被引量:16
  • 4Hendige AM,Saxtorius E,Tschritter O. Tissue selectivity of insulin detemir action in vivo[J].{H}DIABETOLOGIA,2006.1274-1282.
  • 5Gschwend MH,Aagren M,Valentine WJ. Cost-effectiveness of insulin detemir compared with neutral protamine Hagedorn insulin inpatients with type 1 diabetes using a basal-bolus regimen in five European countries[J].J Med Econ,2009.114-123.

共引文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部